HOME >> BIOLOGY >> NEWS
Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds

CHICAGO Obtaining complete and accurate medication histories of patients and instituting a medication reconciliation program are vital to reducing medication errors, a new study conducted at Northwestern Memorial Hospital has shown. The study demonstrated that when hospital pharmacists perform medication reconciliation, taking steps to ensure patients receive the correct medication and accurate dosage, the number of medication errors dropped and with them the potential for patient injury.

"A medication error, once in a patient's medical record, can carry-over from admission through discharge unless medication reconciliation is performed," says Kristine Gleason, who is on the hospital's Patient Safety Team and is the lead author of the study, Reconciliation of Discrepancies in Medication Histories and Admission Orders of Newly Hospitalized Patients. "Doctors, nurses, pharmacists and patients often just assume medical histories are accurate, and that's not always the case."

The study findings, published this week in the American Journal of Health-System Pharmacy, are particularly significant in light of the recent announcement by the Joint Commission on Accreditation of Healthcare Organizations that medication reconciliation for all hospital patients is one of its 2005 National Patient Safety Goals. That means medication reconciliation programs are a requirement for accreditation.

Northwestern Memorial is working toward that goal, implementing a computerized prescriber order entry (CPOE) system as part of its patient safety initiative. A previous study at Northwestern Memorial found that a combination of pharmacist involvement and a CPOE system with significant clinical decision support will likely provide the best approach to improve medication safety among patients.

Data collected by Northwestern Memorial researchers for the new study showed that in the absence of a pharmacist intervention, 22 percent of medication discrepan
'"/>

Contact: Andrew Buchanan
anbuchan@nmh.org
312-926-6503
Northwestern Memorial Hospital
16-Aug-2004


Page: 1 2 3

Related biology news :

1. Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients
2. Common Anti-Viral Medication Prevents Severe Eye Herpes
3. New Medication Means New Choices For Families Dealing With Alzheimers Disease
4. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
5. Call for greater involvement of developing world scientists in fight against AIDS
6. Yale researchers shed light on B cells involvement in autoimmune diseases like lupus
7. Education, monitoring vital for sport-fish eaters
8. Life goes on without vital DNA
9. Rb2 expression could play vital role in ovarian cancer Temple University researchers find
10. Vascular access vital to pump up tissue engineering
11. Study links amyloid plaques in Alzheimers brains to genes vital to normal memory

Post Your Comments:
(Date:1/22/2015)... 2015 Infinisource has launched its new NXG series of ... G2 sets a higher standard for collecting attendance and labor ... With plug-and-play installation, touch screen interface and seamless connection to ... time collection solution for the small to mid-size employer. ...
(Date:12/22/2014)... DENVER , Dec. 22, 2014  The 2014 Holiday ... industry as Acuity Market Intelligence reports that the long ... Acuity forecasts that intensifying demand for smart phones, tablets, ... a global market of 2.5 billion users with nearly ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
(Date:1/22/2015)... Boston, MA (PRWEB) January 22, 2015 ... systems, is pleased to announce an exciting product from a ... of motion analysis solutions over the past 15 years, with ... industries. Most recently, their 3D IMU system (inertial measurement unit), ...
(Date:1/22/2015)... Diagenode, Inc., a leading global ... and complete solutions for epigenetics research, recently launched ... the need for manual processing. The new ChIPettor ... of histones or transcription factors and a semi-automated ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
Cached News: